UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041991
Receipt number R000047926
Scientific Title Investigation of the mechanism of strabismus onset from analysis of eye movement development in infants
Date of disclosure of the study information 2020/10/02
Last modified on 2022/10/04 13:08:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the mechanism of strabismus onset from analysis of eye movement development in infants

Acronym

Analysis of eye movement development in infants

Scientific Title

Investigation of the mechanism of strabismus onset from analysis of eye movement development in infants

Scientific Title:Acronym

Analysis of eye movement development in infants

Region

Japan


Condition

Condition

strabismus

Classification by specialty

Ophthalmology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate which developmental stage of which eye movement is associated with strabismus onset in childhood by analysis of eye movements of infants without strabismus and infants with strabismus with an eye tracker

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

fixation stability
velocity of saccadic eye movement
binocular coordination of smooth pursuit
binocular coordination of convergence

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Recording eye movement by eye tracking device

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 months-old <=

Age-upper limit

4 years-old >

Gender

Male and Female

Key inclusion criteria

For those who meet the following (1) or (2)
(1) Normal person who is 3 months to less than 4 years old, has no strabismus / ocular motility disorder, and has no disease that may have strabismus / ocular motility disorder.
(2) Have strabismus between the ages of 3 months and 4 years (regardless of definitive diagnosis / suspected case, treatment history)

Key exclusion criteria

Exclude if any of the following items apply
(1) Those who do not wish to participate in this research
(2) Those with irregular pupils
(3) Left-right difference in aversive reaction or left-right difference in visual acuity of 3 levels or more

Target sample size

80


Research contact person

Name of lead principal investigator

1st name MIHARU
Middle name
Last name MIHARA

Organization

University of Toyama

Division name

Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences

Zip code

930-0194

Address

2630 Sugitani, Toyama, Toyama

TEL

076-434-7363

Email

miharu@med.u-toyama.ac.jp


Public contact

Name of contact person

1st name MIHARU
Middle name
Last name MIHARA

Organization

University of Toyama

Division name

Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences

Zip code

930-0194

Address

2630 Sugitani, Toyama, Toyama

TEL

076-434-7363

Homepage URL


Email

miharu@med.u-toyama.ac.jp


Sponsor or person

Institute

University of Toyama

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee, University of Toyama

Address

2630 Sugitani, Toyama, Toyama

Tel

076-434-7681

Email

rinri@adm.u-toyama.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 06 Month 08 Day

Date of IRB

2020 Year 09 Month 07 Day

Anticipated trial start date

2020 Year 09 Month 07 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2020 Year 10 Month 02 Day

Last modified on

2022 Year 10 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047926


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name